Skip to content

Observational Study on Traditional Chinese Medicine Intervention for the Characteristics of Chronic Obstructive Pulmonary Disease

Observational Study on Traditional Chinese Medicine Intervention for the Characteristics of Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000905
Enrollment
Unknown
Registered
2026-04-09
Start date
2025-10-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with stable chronic obstructive pulmonary disease (COPD) or pre-COPD. (2) Age: 30 to 80 years old. (3) The condition was stable 4 weeks before enrollment; (4) No participation in other drug clinical studies within 1 month before enrollment. (5) Sign the informed consent form

Exclusion criteria

Exclusion criteria: Patients with severe or acute cardiovascular and cerebrovascular diseases (acute cardiovascular and cerebrovascular events, malignant arrhythmias, unstable angina pectoris, grade 3 or above cardiac function, uncontrolled hypertension, etc.). (2) Combined with severe liver and kidney diseases (severe liver diseases refer to liver cirrhosis, portal hypertension and bleeding from varicose veins, and severe kidney diseases include dialysis and kidney transplantation). (3) Any one of the liver function indicators (ALT or AST) exceeds the upper limit of the normal reference value by 15 times, and the renal function indicator Scr exceeds the upper limit of the normal reference value. (4) Tumor patients who have undergone surgical resection, radiotherapy and chemotherapy in the past five years. (5) Those who have difficulty moving due to severe osteoarthropathy, neuromuscular disease or peripheral vascular disease. (6) Situations where the absolute or relative prohibition of the 6-minute walk test is combined: such as resting heart rate >120 beats per minute, systolic blood pressure >180mmHg or diastolic blood pressure >100mmHg; Or due to limited activities, it is difficult to complete the 6-minute walk test.

Design outcomes

Primary

MeasureTime frame
Demographic information;Disease information (disease duration, number of exacerbations within one year, current inhalation medication use, pulmonary function classification, chronic obstructive pulmonary disease grouping);Syndrome information (Lung qi deficiency syndrome, lung Yin deficiency, deficiency of both lung qi and Yin, lung and kidney qi deficiency syndrome, deficiency of both lung and spleen syndrome, wind-cold syndrome, phlegm-turbidity blocking the lung syndrome, phlegm-heat blocking the lung syndrome, and other syndromes);Auxiliary examinations (blood routine, liver function, kidney function, interleukin, lymphocytes, immunoglobulin, lung function, echocardiography, chest CT);

Countries

CHINA

Contacts

Public ContactXUE Honghao

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

13917327582@163.com18917763479

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026